Courtney Jarrahian is the Global Program Leader for PATH’s Medical Devices and Health Technologies Program. She oversees collaborations with private- and public-sector partners to accelerate equitable access of vaccine and pharmaceutical packaging, formulation, and delivery technologies, and supply chain innovations, as well as innovations for primary health care. Courtney provides strategic direction and guidance based on her 20 years of experience in health technology research and development focused on medical devices and combination products. Her work integrates user-centered design, technical development, human factors evaluation, health economics, manufacturing, regulatory pathways, and commercialization. Since 2018, she has served as the director of PATH’s Microarray Patch Center of Excellence, which focuses on generating data on the potential for this technology to improve delivery of measles-rubella vaccine as well as other vaccines and medications for critical global health needs. She is also a member of the Vaccine Innovation Prioritization Strategy (VIPS) alliance, coordinating with global partners to advance microarray patches and other potentially transformative innovations for immunization.